Bespoke Extracts, Inc.

Equities

BSPK

US08634Q2084

Pharmaceuticals

Market Closed - OTC Markets 19:57:56 22/05/2024 BST 5-day change 1st Jan Change
0.13 USD +57.43% Intraday chart for Bespoke Extracts, Inc. -7.14% +266.20%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bespoke Extracts, Inc. announced that it has received $0.1 million in funding CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Bespoke Extracts, Inc. entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million. CI
Bespoke Extracts, Inc. announced that it has received $0.0922 million in funding from Infinity Management LLC and other investors CI
Bespoke Extracts, Inc. announced that it expects to receive $0.0922 million in funding from Infinity Management LLC and other investors CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021 CI
Bespoke Extracts, Inc. Changes Fiscal Year from August 31 to December 31 CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021 CI
Bespoke Extracts, Inc. announced that it has received $0.25 million in funding CI
Bespoke Extracts, Inc. announced that it expects to receive $0.25 million in funding CI
Bespoke Extracts, Inc. Announces Appointment of Hunter Garth as President CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended August 31, 2021 CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt CI
Bespoke Extracts, Inc. agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million. CI
Infinity Management LLC completed the acquisition of 20.1% stake in Bespoke Extracts, Inc. from Danil Pollack. CI
Bespoke Extracts, Inc. Announces Management Changes CI
Chart Bespoke Extracts, Inc.
More charts
Bespoke Extracts, Inc. operates in the regulated cannabis markets in the United States. The Company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Box-O-Joints, and Wee Joints, to licensed marijuana dispensaries across Colorado. Through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC, the Company operates Wonderleaf LLC (WonderLeaf), a marijuana-infused products production facility in Aurora, Colorado. The Company manufactures a range of premium pre-rolled joints. The Company has offered cannabis products focusing on two primary categories: Branded Products and Processing Business. It plans to pursue production of brands of pre-rolled joints and other processed marijuana products under newly created brand names. It also plans to explore licensing existing brands from other states and producing them in Colorado.
More about the company
  1. Stock Market
  2. Equities
  3. BSPK Stock
  4. News Bespoke Extracts, Inc.
  5. Insider Trends: Insider Buying Continued with Purchase of Bespoke Extracts Stock